Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection

Código QR

Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection

Wissam El-Hage1, Simon A Surguladze21Inserm U930 ERL CNRS 3106, Universit&eacute; Fran&ccedil;ois Rabelais and Clinique Psychiatrique Universitaire, CHRU de Tours, Tours, France; 2Institute of Psychiatry, King&rsquo;s College London, UKAbstract: Bipolar disorder is a life-lon...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wissam El-Hage, Simon A Surguladze
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/9438f72e3cf64499a36e8bf6a82f9197
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louz&atilde; M, et al.
Publicado: (2011)

Risperidone long-acting injection: a review of its long term safety and efficacy
por: Michael K Rainer
Publicado: (2008)

Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
por: Michele Fabrazzo, et al.
Publicado: (2021)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs L, et al.
Publicado: (2013)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
por: Dhiren Singh, et al.
Publicado: (2009)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
por: Zhao Y, et al.
Publicado: (2013)

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Joseph Biederman, et al.
Publicado: (2008)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic M, et al.
Publicado: (2018)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Jeffrey R Bishop, et al.
Publicado: (2008)

Long-acting injectable antipsychotics: focus on olanzapine pamoate
por: JP Lindenmayer
Publicado: (2010)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009)

Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
por: Torres-Llenza V, et al.
Publicado: (2018)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts RJ, et al.
Publicado: (2016)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao K, et al.
Publicado: (2013)

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Mario Louz&atilde;, et al.
Publicado: (2010)

Screening for bipolar disorder among migraineurs: the impact of migraine–bipolar disorder comorbidity on disease characteristics
por: Kivilcim Y, et al.
Publicado: (2017)

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
por: Narita Z, et al.
Publicado: (2017)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Roberto Canitano, et al.
Publicado: (2008)

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
por: Sajatovic M, et al.
Publicado: (2018)

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
por: Fernandez C, et al.
Publicado: (2019)

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication
por: Andor M, et al.
Publicado: (2019)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew Y, et al.
Publicado: (2015)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

First-line therapy of chronic myeloid leukemia &ndash; focus on dasatinib
por: Amrein PC
Publicado: (2012)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009)

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
por: Mannu P, et al.
Publicado: (2011)

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
por: Rosaria Di Lorenzo, et al.
Publicado: (2010)

Update on treatment options for Lambert&ndash;Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist S, et al.
Publicado: (2011)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton N, et al.
Publicado: (2018)

Current trends in drug treatment of obsessive&ndash;compulsive disorder
por: Eric H Decloedt, et al.
Publicado: (2010)

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
por: Salzman PM, et al.
Publicado: (2017)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum H, et al.
Publicado: (2014)

Aripiprazole augmentation in managing comorbid obsessive–compulsive disorder and bipolar disorder: a case with suicidal attempts
por: Lai J, et al.
Publicado: (2016)

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
por: Brasso C, et al.
Publicado: (2017)

Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
por: Natalia N. Petrova, et al.
Publicado: (2020)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2019)

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study
por: Chiu LL, et al.
Publicado: (2019)

Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
por: Watanabe Y, et al.
Publicado: (2017)

Risperidone-induced reversible neutropenia
por: Kattalai Kailasam V, et al.
Publicado: (2017)

The efficacy of Li in bipolar disorder
por: Lozano R, et al.
Publicado: (2013)